High Regulation and Low Certainty: Marketing Strategy Challenges for the Pharmaceutical Industry in China

2015 ◽  
Vol 16 (1) ◽  
pp. 1-12
Author(s):  
Sharon Thach
Keyword(s):  
Open Access ◽  
Pharmaceutical Industry ◽  
Marketing Strategy ◽  
Prescription Drugs ◽  
Pharmaceutical Companies ◽  
Industrial Setting ◽  
Industry Environment ◽  
Rules Of The Game

The opening of China to foreign pharmaceutical companies created essentially a new market where the “rules of the game” were not previously established for the particular industrial setting. The regulations governing access to prescription drugs, the role of pharmaceuticals in providing funding for hospitals and clinics, and the low oversight of company practices resulted in a system of mutual corruption, high competition, and shifting regulatory and legal formalities. As the movement to open access to pharmaceuticals to non-hospital purveyors and the attention of Chinese authorities to certain industry practices has proceeded, the industry environment has changed significantly. Four possible new competitive models for pharmaceutical companies are evaluated.

scholarly journals Pharmacotherapy and child psychiatry: is there a way forward?

2008 ◽  
Vol 14 (1) ◽  
pp. 10-16 ◽  
Author(s):  
A. James
Keyword(s):  
Pharmaceutical Industry ◽  
Child Psychiatry ◽  
New Drugs ◽  
Pharmaceutical Companies ◽  
Drug Treatments ◽  
New Guidelines ◽  
Post Trial ◽  
Relationship Of ◽  
The Relationship

Recent controversy over the use of serotonin reuptake inhibitors in children and adolescents has focused attention on the role of the pharmaceutical industry in the treatment of young people. Failure of pharmaceutical companies to fully disclose negative outcome trials has led to new guidelines for publication of all trial results. Scrutiny is on the conduct of trials and the relationship of the pharmaceutical industry with prescribing doctors and post-trial surveillance of new drugs. It is argued that drug treatments in child psychiatry are a powerful therapeutic tool but vigilance is needed to ensure that data on the efficacy and safety of drugs are freely available.

Blockbuster Drugs

2014 ◽  
Author(s):  
Jie Jack Li
Keyword(s):  
Drug Discovery ◽  
Pharmaceutical Industry ◽  
Prescription Drugs ◽  
Business Models ◽  
Scientific Discovery ◽  
New Drugs ◽  
Pharmaceutical Companies ◽  
Blockbuster Drug ◽  
A Minor ◽  
Future Landscape

For the world's largest prescription drug manufacturers, the last few years have been a harrowing time. Recently, Pfizer's Lipitor, GlaxoSmithKline's Advair, AstraZeneca's Seroquel, and Sanofi-Aventis and Bristol-Myers Squibb's Plavix all came off patent in the crucial U.S. market. This so-called "patent cliff" meant hundreds of billions of dollars in lost revenue and has pharmaceutical developers scrambling to create new drugs and litigating to extend current patent protections. Having spent most of his career in drug discovery in "big pharma," Dr. Li now delivers an insider's account of how the drug industry ascended to its plateau and explores the nature of the turmoil it faces in the coming years. He begins with a survey of the landscape before "blockbuster drugs," and proceeds to describe how those drugs were discovered and subsequently became integral to the business models of large pharmaceutical companies. For example, in early 1980s, Tagamet, the first "blockbuster drug," transformed a minor Philadelphia-based drug maker named SmithKline & French into the world's ninth-largest pharmaceutical company in terms of sales. The project that delivered Tagamet was nearly terminated several times because research efforts begun in 1964 produced no apparent results within the first eleven years. Similar stories accompany the discovery and development of now-ubiquitous prescription drugs, among them Claritin, Prilosec, Nexium, Plavix, and Ambien. These stories, and the facets of the pharmaceutical industry that they reveal, can teach us valuable lessons and reveal many crucial aspects about the future landscape of drug discovery. As always, Dr. Li writes in a readable style and intersperses fascinating stories of scientific discovery with engaging human drama.

scholarly journals Assessing the functionality of models for predicting pharmaceutical companies

2020 ◽  
Vol 9 (28) ◽  
pp. 272-280
Author(s):  
Danil Alekseevich Zyukin ◽  
Alexey Anatolyevich Golovin ◽  
Olga Viktorovna Pshenichnikova ◽  
Marina Nikolaevna Nadzhafova
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Stability ◽  
Pharmaceutical Companies ◽  
Strategic Role ◽  
Important Direction ◽  
Standard Models ◽  
Probability Of Bankruptcy ◽  
The Russian Federation

The article considers the problem of the functionality of existing bankruptcy forecasting models for the pharmaceutical industry, the significance of which is due to the strategic role of this industry in ensuring drug safety in Russia. In conditions of import dependence, it is possible to increase the competitiveness of domestic enterprises by investing in it, which actualizes the task of increasing their investment attractiveness, one of the main elements of which is long-term and predictable financial stability. The study shows that today the assessment of financial stability and the likelihood of bankruptcy is possible only on the basis of generalized models of domestic and foreign authors, which in general give ineffective results. This is due to the fact that standard models do not take into account the industry specifics of the enterprises in question, and therefore are not able to reliably determine the presence or absence of a threat of insolvency. An important direction in the development of the pharmaceutical industry of the Russian Federation in the current environment is the search for effective tools for economic analysis and the development of the correct adapted methodology for predicting the probability of bankruptcy.

scholarly journals Revisiting the Role of Traditional, Electronic and Mobile-Based Communication Channels in the Pharmaceutical Industry of Lithuania

2020 ◽  
Vol 26 (5) ◽  
pp. 541-550
Author(s):  
Vilte Auruskeviciene ◽  
Jovita Butkeviciene ◽  
Laura Salciuviene
Keyword(s):  
Prescription Drugs ◽  
Medical Information ◽  
Age Groups ◽  
International Health ◽  
Communication Channels ◽  
Pharmaceutical Companies ◽  
Drug Prescribing ◽  
Pharmaceutical Sales ◽  
Channel Preferences

The study revisits communication channels currently used to access medical information and investigates perceptions of general practitioners (GPs) about traditional, electronic and mobile-based channels in the context of Lithuania. A total of 254 GPs were surveyed. The findings suggest that the pharmaceutical companies still rely on pharmaceutical sales representatives to disseminate the newest information about prescription drugs. The results indicate that the leading experts in the healthcare industry contribute most to GPs’ drug-prescribing intentions and conferences organised by local and international scientific societies are considered to be the most reliable channels. Further, local websites designed for GPs have the highest perceived value among electronic and mobile-based communication channels. Statistically significant differences among different GPs’ age groups are confirmed regarding channel preferences and their reliability: international scientific conferences and international health journals are more popular and are perceived as more reliable among younger GPs compared to more senior GPs. DOI: http://dx.doi.org/10.5755/j01.ee.26.5.12510

Russia’s Market of Mergers and Acquisitions: Stages, Features and Prospects

2009 ◽  
pp. 23-45 ◽  
Author(s):  
A. Radygin
Keyword(s):  
Open Access ◽  
Mergers And Acquisitions ◽  
Corporate Control ◽  
Active Role ◽  
Data Bases ◽  
2008 Financial Crisis ◽  
Legal Norms ◽  
Role Of The State ◽  
Access Data

The article deals with key tendencies in the development of Russia’s market of mergers and acquisitions in the first decade of the 21st century. Quantitative parameters are analyzed by using available in the open access data bases for the years 2003-2008 taking into consideration new tendencies relating to 2008 financial crisis. An active role of the state played in the market of corporate control represents an important factor. Special attention is given to issues of development of Russia’s system of legal norms regulating the market of mergers and acquisitions.

Making gender visible in family business: past and present

2012 ◽  
Vol 13 (1) ◽  
Author(s):  
Paloma Fernández Pérez ◽  
Eleanor Hamilton
Keyword(s):  
Family Business ◽  
Family Firms ◽  
Business Leadership ◽  
Legal Rules ◽  
Developed Economies ◽  
The Family ◽  
Interdisciplinary Synthesis ◽  
Complex Forms ◽  
Rules Of The Game

This  study  contributes  to  developing  our understanding of gender and family business. It draws on studies from the business history and management literatures and provides an interdisciplinary synthesis. It illuminates the role of women and their participation in the entrepreneurial practices of the family and the business. Leadership is introduced as a concept to examine the roles of women and men in family firms, arguing that concepts used  by  historians or economists like ownership and management have served to make women ‘invisible’, at least in western developed economies in which owners and managers have been historically due to legal rules  of  the  game  men,  and  minoritarily women. Finally, it explores gender relations and  the  notion  that  leadership  in  family business  may  take  complex  forms  crafte within constantly changing relationships.

The Role Of Motion Games On The Development Of Children With Special Needs In The Primary Cycle

2019 ◽  
pp. 21-27
Author(s):  
Iuliana-Luminita Constantin ◽  
Marin Chirazi
Keyword(s):  
Special Needs ◽  
Special School ◽  
Children With Special Needs ◽  
Typical Development ◽  
Special Educational Needs ◽  
Number Of Children ◽  
Regular School ◽  
Primary Cycle ◽  
Rules Of The Game

The purpose of this research is to highlight the role of the games of movement on the development and social integration of children with special educational requirements from the primary cycle, studying the theme in the literature. According to statistics in the field over the last years, there has been an increase in the number of children with special needs in regular schools. Thus, children who a few years ago would have been included in a special school, today have facilities at a regular school, along with children with typical development and have a similar curriculum to follow [7]. This is why motion games are a method, an important opportunity to integrate children with special requirements in a collective, because through them children cooperate (working in groups or pairs) making new friends, no longer feeling rejected, communication becomes easier, collaborates to achieve the goal of the game, support each other, become more responsible by observing the rules of the game and accept each other as they are. The game develops the ability to adapt easily to new situations, increases effort capacity, teaches children to be careful and develops their confidence. Due to the fact that movement games are performed more in group, they provide socialization, but they must be adapted according to the child's deficiency. Conclusion: We have found that motion games are an effective way to integrate children with special educational needs into a collective, because through them children make new friends easier, they are accepted in collectivity, communication becomes easier, they support and understand each other and most importantly accepted as they are. Through the game children feel free to act.

Chiral separation and analysis of antifungal drugs by chromatographic and electromigration techniques: Results achieved in 2010–2020

2021 ◽  
Vol 40 (1) ◽  
pp. 220-252
Author(s):  
Giovanni D’Orazio ◽  
Chiara Fanali ◽  
Chiara Dal Bosco ◽  
Alessandra Gentili ◽  
Salvatore Fanali
Keyword(s):  
Gas Chromatography ◽  
Pharmaceutical Industry ◽  
State Of The Art ◽  
Stationary Phases ◽  
Enantiomeric Separation ◽  
Antifungal Drugs ◽  
Chiral Discrimination ◽  
Food Science ◽  
Industry Environment ◽  
Metabolic Activities

Abstract The determination and separation of enantiomers is an interesting and important topic of research in various fields, e.g., biochemistry, food science, pharmaceutical industry, environment, etc. Although these compounds possess identical physicochemical properties, a pair of enantiomers often has different pharmacological, toxicological, and metabolic activities. For this reason, chiral discrimination by using chromatographic and electromigration techniques has become an urgent need in the pharmaceutical field. This review intends to offer the “state of the art” about the separation of chiral antifungal drugs and several related precursors by both liquid and gas chromatography, as well as electromigration methods. This overview is organized into two sections. The first one describes general considerations on chiral antifungal drugs. The second part deals with the main analytical methods for the enantiomeric discrimination of these drugs, including a brief description of chiral selectors and stationary phases. Moreover, many recent applications attesting the great interest of analytical chemists in the field of enantiomeric separation are presented.

Fake Pharmaceuticals: How They and Relevant Legislation or Lack Thereof Contribute to Consistently High and Increasing Drug Prices

2003 ◽  
Vol 29 (4) ◽  
pp. 525-542
Author(s):  
Merri C. Moken
Keyword(s):  
United States ◽  
Prescription Drugs ◽  
The United States ◽  
Pharmaceutical Products ◽  
New Drugs ◽  
Pharmaceutical Companies ◽  
Brand Name ◽  
Potential Factors ◽  
Counterfeit Pharmaceuticals ◽  
New Applications

The use of pharmaceutical products in the United States has increased more than the use of any other health resource from 1960 to 1990. In excess of 9,600 drugs were on the market in 1984, and the Food and Drug Administration (“FDA”) approves approximately 30 new drugs and countless new applications for alterations of already existing drugs each year. In 2001, the $300 billion pharmaceutical industry sold $154 billion worth of prescription drugs in the United States alone, nearly doubling its $78.9 billion in sales in 1997. With such a rapid increase in market domination and expenditures, the U.S. government and many hospitals have focused their attention on the sales and pricing practices of pharmaceutical companies, as well as other potential factors contributing to these escalating prices. One such cause of the steadily increasing prices of brand name pharmaceuticals is the sale of fake or counterfeit pharmaceuticals (also called “look-alike” drugs).

Sign in / Sign up

Export Citation Format

Share Document